Back to results
US 2016/0106686 A1Published application
Multilaminate backing construction
AssigneeAlza Corporation
InventorJay Douglas Audett
Life of this patent
Estimating the term…
Abstract
A novel backing construction for a transdermal drug delivery system is disclosed. In particular, the invention relates to a system and method for labeling a transdermal drug delivery system, wherein the backing layer contains a writable medium capable of inkless printing.
Claims21
1-17. (canceled)
A method of making a transdermal drug delivery device, the method comprising:
- forming a device comprising a primary drug-containing reservoir and multilaminate backing construction,
- wherein the primary drug-containing reservoir comprises a primary drug selected from the group consisting of a therapeutic agent and an antagonist, and
- wherein the multilaminate backing construction comprises
- (a) an outer layer,
- (b) a tie layer comprising a secondary drug-containing reservoir comprising a secondary drug selected from the group consisting of an antagonist and a therapeutic agent, wherein the secondary drug is different from the primary drug, and
- (c) a base layer.
3 more elements
A method of making a transdermal drug delivery device, the method comprising:
- obtaining a primary drug-containing reservoir comprising a primary drug selected from the group consisting of a therapeutic agent and an antagonist;
- obtaining a multilaminate backing construction comprising
- (a) an outer layer,
- (b) a tie layer comprising a secondary drug-containing reservoir comprising a secondary drug selected from the group consisting of an antagonist and a therapeutic agent, wherein the secondary drug is different from the primary drug, and
- (c) a base layer;
- and
- coupling the primary drug-containing reservoir to the multilaminate backing construction.
4 more elements
Dependencies are inferred from the claim text.